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Background There is an emerging body of literature suggesting that the evidence-practice divide in health
policy is complex and multi-factorial but less is known about the processes by which health policy-makers use
evidence and their views about the specific features of useful evidence. This study aimed to contribute to
understandings of how the most influential health policy-makers view useful evidence, in ways that help
explore and question how the evidence-policy divide is understood and what research might be supported to
help overcome this divide. Methods A purposeful sample of 18 national and state health agency CEOs from 9
countries was obtained. Participants were interviewed using open-ended questions that asked them to define
specific features of useful evidence. The analysis involved two main approaches 1)quantitative mapping of
interview transcripts using Bayesian-based computational linguistics software 2)qualitative critical discourse
analysis to explore the nuances of language extracts so identified. Results The decision-making, conclusionsoriented world of policy-making is constructed separately, but not exclusively, by policy-makers from the
world of research. Research is not so much devalued by them as described as too technical— yet at the same
time not methodologically complex enough to engage with localised policy-making contexts. It is not that
policy-makers are negative about academics or universities, it is that they struggle to find complexity-oriented
methodologies for understanding their stakeholder communities and improving systems. They did not
describe themselves as having a more positive role in solving this challenge than academics. Conclusions
These interviews do not support simplistic definitions of policy-makers and researchers as coming from two
irreconcilable worlds. They suggest that qualitative and quantitative research is valued by policy-makers but
that to be policy-relevant health research may need to focus on building complexity-oriented research
methods for local community health and service development. Researchers may also need to better explain
and develop the policy-relevance of large statistical generalisable research designs. Policy-makers and public
health researchers wanting to serve local community needs may need to be more proactive about questioning
whether the dominant definitions of research quality and the research funding levers that drive university
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Abstract
Background: There is an emerging body of literature suggesting that the evidence-practice divide in health policy
is complex and multi-factorial but less is known about the processes by which health policy-makers use evidence
and their views about the specific features of useful evidence. This study aimed to contribute to understandings of
how the most influential health policy-makers view useful evidence, in ways that help explore and question how
the evidence-policy divide is understood and what research might be supported to help overcome this divide.
Methods: A purposeful sample of 18 national and state health agency CEOs from 9 countries was obtained.
Participants were interviewed using open-ended questions that asked them to define specific features of useful
evidence. The analysis involved two main approaches 1)quantitative mapping of interview transcripts using
Bayesian-based computational linguistics software 2)qualitative critical discourse analysis to explore the nuances of
language extracts so identified.
Results: The decision-making, conclusions-oriented world of policy-making is constructed separately, but not
exclusively, by policy-makers from the world of research. Research is not so much devalued by them as described
as too technical— yet at the same time not methodologically complex enough to engage with localised
policy-making contexts. It is not that policy-makers are negative about academics or universities, it is that they
struggle to find complexity-oriented methodologies for understanding their stakeholder communities and
improving systems. They did not describe themselves as having a more positive role in solving this challenge than
academics.
Conclusions: These interviews do not support simplistic definitions of policy-makers and researchers as coming
from two irreconcilable worlds. They suggest that qualitative and quantitative research is valued by policy-makers
but that to be policy-relevant health research may need to focus on building complexity-oriented research
methods for local community health and service development. Researchers may also need to better explain and
develop the policy-relevance of large statistical generalisable research designs. Policy-makers and public health
researchers wanting to serve local community needs may need to be more proactive about questioning whether
the dominant definitions of research quality and the research funding levers that drive university research
production are appropriately inclusive of excellence in such policy-relevant research.
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Background
Generalisable, big-N quantitative biomedical, rather than
local community health and services research, heavily
dominates health research funding programs. The USA
is by far the biggest producer of that research— almost a
quarter of the approximately 22 million research items
in the database PUBMED are from the USA, although
the USA has 4% of the total global population [1,2]. It
has been estimated that the USA spends an estimated
1.5% of all health research funding on health services research [3]. The situation is similar in other developed
countries, for example, the Health and Medical Research
Council in Australia spends 3.8% of its funding on health
services research [2,4].
However, there is growing concern about the extent
to which this hierarchy of quality and the priorities it
shapes for funded research translates into community
benefits. A watershed report in 2001 Crossing the Quality
Chasm by the USA Institute of Medicine suggested that
the emphasis on generalisable discovery science has not
translated well into innovations for community benefits
and healthcare system development [5]. It has been claimed that, in most journals in the clinical sciences literature, less than 1% of published journal papers are
clinically relevant [6,7]. Doubts are being raised about a
too singular reliance on traditional high-powered big-N
randomised clinical research approaches, as well as systematic reviews based on such evidence, for the multifactorial decision-making contexts of clinical practice [6-11].
Such concerns about the translation of research into
tangible benefits instigated the USA’s National Institutes
of Health’s 21st Century research roadmap for translational research. The developing science of ‘translational
research’ for clinical practice and associated journals such
as Implementation Science and Translational Research are
part of a growing body of 21st Century research literature on the evidence-practice divide [11]. ‘Translational
science’ has taken a strong ‘laboratory bench to clinical
bedside’ (‘T1’) focus, as well as ‘clinical research to clinical
practice’ (‘T2’) focus [1,12,13]. Concerns about evidence
translation have also led to the ‘comparative effectiveness
research’ (CER) movement, initially supported by a number of influential agencies such as the USA’s Institute of
Medicine, National Institutes of Health, and the Agency
for Healthcare Research and Quality, developing more
systematic evidence for understanding intervention effectiveness in ways that inform practice and policy [14].
However, questions about the social usefulness of evidence that has a too singular reliance on narrow biomedical research paradigms—high-powered quantitative
randomised clinical trial designs—are certainly not restricted to medicine. In public health research, influential
voices such as Evans and Stoddart have argued that an
engagement with the contextual evidence on the social
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determinants of health—most useful to addressing the
true underlying causal factors at work in unequal health
outcomes—are not well served by narrow biomedical research paradigms [15,16]. The large body of literature
on the social determinants of health, including for rural
and traditional indigenous societies, points to the local
and contextual socio economic shapers of health, including health literacy and health behaviours shaped by culture [17-25].
More broadly, popular and scholarly critiques of the
relevance of research have suggested that, in the late
20th and early 21st Centuries, quantitatively sophisticated
research has come to be associated with undemocratic
styles of policy-making serving narrow economic interests
[26,27]. These arguments have suggested that quantitative
research has been increasingly used as an instrument of
policy-making practices that are removed from the wider
interests of society [26,27]. For example, a too singular reliance or ‘trust in numbers’ has been seen by historians of
research methods as part of a historical shift in modern
policy-making towards techniques of power that are (paradoxically) less rather than more accountable—distancing
evidence from the experiences and views of local communities [28]. In such arguments, rightly or wrongly, big-N
statistical research methods are seen as instrumental to
the creation of a culture of mistrust of research that may
itself be part of the research translation divide [26,27].
There is also a growing body of literature suggesting
that the evidence-policy divide in health is complex and
multi-factorial. The developing discipline of health policy studies has been led by Davies and Nutley [29] in the
United Kingdom where much of the drive of ‘modernising’ the public service originated with the Blair government which produced a wide range of initiatives aimed
at developing evidence-based policy-making. Drawing on
the work of Weiss, Davies and Nutley suggest the complexity of evidence take-up. They describe different ways
in which evidence can be used in policy-making, ranging
from rational and deliberative, to strategic and political,
to justifying a pre-determined position, to using evidence
as a delaying tactic [29,30].
Accordingly, the translational challenge in policy can be
understood in terms of multiple lines of ‘two-way’ translation from policy-makers to their communities of interest
(stakeholder groups) and vice versa. It can also be understood in terms of evidence translation from policy-makers
to health services, evidence translation across different
kinds of health services, and evidence translation from
health services to practitioners and ultimately patients.
This study is an analysis of what research methods policymakers perceive as useful: sometimes this involves focussing on the health-policy divide while other times
it involves a focus on wider issues of research-policypractice translation.
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Over the last decade in particular, the barriers to research translation in health policy have been understood
as being about a wide range of factors such as the inherently political nature of policy-making [31], the differing
strategic priorities of policy [32], the difficulty of capturing different stakeholder interests that lie outside ‘best
practice evidence’ [33], and the ‘real world’ contextual
constraints of policy decision-making [34]. The ‘two
worlds’ view of the evidence-policy divide—that policymakers are from Mars and researchers are from Venus
—has appeared to dominate ways of understanding the
evidence-policy divide [35].
However, some policy researchers and social scientists
have argued that the evidence-practice divide is also about
how traditional quantitative research methods sometimes
do not translate well to policy because they have certain
homogenising and simplifying tendencies [36]. This is essentially an argument that the evidence-policy divide is
also about the technical limitations of big-N statistical research methods [33,37]. This is, of course, a criticism that
can arguably be made of many research approaches, including qualitative methods. In such arguments though,
technical aspects of statistical evidence are seen as having
an apparent complexity to lay audiences while also simplifying or homogenising complex causality with ‘correlational thinking’ [38]. A related argument in some health
policy literature is the suggestion that there is a mismatch
between the generalisability focus of biomedical and epidemiological research and the local community and service development needs of policy-makers i.e. that this
mismatch has also helped widen the divide [39-41]. Such
arguments do align to some extent with sophisticated
contemporary discussion by luminaries such as Poole,
Goodman and Ioannidis in debates in the clinical methods
and epidemiology literature about the simplistic and widespread use of p-values to interpret data [42-44]. Thus,
arguments about certain features of big-N quantitative
methods as themselves representing a barrier to overcoming the evidence-policy divide have focussed on the
simplifying nature of p-values and the perceived failure
of big-N high powered studies to capture small-N rich
local contexts.
Are such arguments accurate representations of the
evidence-practice divide, even partly? Further exploration
of this issue is important to those who are interested in
learning about what researchers can do to develop more
policy-relevant approaches. Clearly, a number of studies
are needed to empirically validate such views, including
data on policy-makers’ perceptions of the evidence-policy
divide. However, to date there has not been a study exploring whether and how the most senior policy-makers
might agree with this argument i.e. that the evidencepractice divide is to some extent an artefact of specific limitations of research methods. Senior policy-makers—such
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as CEOs of major national and provincial health agencies
—could be viewed as critical witnesses and shapers of the
interface between health systems and political decisionmaking and of evidence and policy.
This study aimed to explore whether the most influential policy-makers see a research-policy divide and if so,
whether they see particular research methods as part of
the challenge of bridging the evidence-policy divide. In
particular, the study aimed to better understand whether
and how policy-makers described particular research
methods as less or more able to engage with their local
contextual needs—and whether they perceive the methodological challenge of capturing local context as part of
the evidence-policy divide.

Methods
This study combines two methods—one novel and based
on computational linguistics and a second using traditional critical discourse analyses. Therefore, it is termed
a ‘critical computational linguistics’ approach. In summary,
a purposeful, pragmatic sample of 18 national and state
health agency CEOs from 9 countries was obtained. Participants were interviewed using open-ended questions that
asked them to define specific features of useful evidence.
The analysis involved two main approaches 1) quantitative
mapping of interview transcripts using Bayesian-based
computational linguistics software to measure the presence and relative frequency of co-occurrence of key
concepts and 2) qualitative critical discourse analysis to
explore the nuances of language extracts so identified.
The study sample and interview procedure

The participants were recruited by direct email and telephone to leading government health agencies in OECD
countries, as well as health agencies in two health systems that could provide a Chinese and Asian perspective and met the criteria of publishing at least some of
their policy documents in English (Hong Kong and
Singapore). In the case of the USA and the UK, regional
and state health agency CEOs were also approached, as
these two countries disproportionately lead evidence production in the developed world. The study used a ‘first
past the post’ approach in which no further recruitment
was undertaken once 18 health CEO interviews had been
obtained (we judged this number to be sufficient for
our purposes and the maximum resources allowed). The
18 interviews comprised 5 interviews from the USA,
4 from the UK, 2 from Australia, and one each from
New Zealand, Canada, Norway, Denmark, Singapore, and
Hong Kong. The response rate to the initial approach
to policy-makers was about 50% i.e. about 36 agencies
had been approached by the time 18 participants were
recruited. Interviews were conducted from March to
May 2009.
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Accordingly, the recruitment method maximised the
chances of obtaining policy-makers who were most interested in research translation issues and/or had a particular interest in communicating their views about
such issues to research communities. The names of health
agencies cannot be supplied as a condition of our ethics
committee approval, as this would immediately identify
their CEOs. However, all agencies shared the criteria of
being leading government health agencies directly involved in delivering healthcare and developing policy. The
CEOs interviewed had a major role in deciding health system policy in their country and operated at the interface
of that health system and political decision-making in
their country.
Interviews were of 45–60 minutes in length and were
conducted by EB using open-ended questions, sent to
policy-makers beforehand, which asked policy-makers to
define specific features of useful evidence. Interviews were
prefaced by advice designed to encourage policy-makers
to view themselves as experts in the research methods
needed for their contexts:

3. What’s the best way for researchers to find out about
the policy challenges they need to address in their
research?
4. What do researchers need to cover when they do
literature reviews for policy decision-makers?
5. What practical advice can you give to researchers
about how to make their research methods more
relevant to your needs?
6. How should researchers work with community
stakeholders to make their research effective for
policy-makers?
7. Can you describe the findings of data analyses
(graphs, tables, narrative analyses etc.) that have/
haven’t worked for the practical needs of policy
decision-making?
8. How should researchers write health policy options
and recommendations that work for you?
9. What practical tips would you give researchers to
help them make sure their research doesn’t sit on a
shelf gathering dust, but rather gets used by policymakers and their communities?

Senior health policy decision-makers are accustomed
to examining a wide range of information and
research evidence for that decision-making. Many of
them have high level qualifications, including research
qualifications and experience. They are also likely to
have experience recruiting, as well as managing or
otherwise advising, researchers for health policy. Thus
they have formed views about the kinds of research
and ways of doing research that work best for health
policy decision-making. The interview questions
below ask you to use your professional judgment and
experience in this area as a health policy decisionmaker to offer practical advice to researchers about
how to better meet your needs.

Interviews were conducted by telephone, audiotaped
and transcribed for analysis.

The interview questions were designed to focus the attention of policy-makers on specific features of research
evidence important to understanding the methodological
barriers to research-policy translation. The questions therefore focussed on research practice from conceptualisation
of the aims of research to the writing of conclusions and
the dissemination of research. The questions were asked
sequentially, as follows:
1. Can you give some practical examples of how
decisions are made about policy—what influences
these decisions? What role does research have in
policy-making?
2. Can you describe the features of a research report
that really met the needs of health policy decisionmaking? What was it about that report that worked
for health policy decision-making?

Analytic procedure

The analysis of the transcribed interviews involved two
main stages.
Stage 1

Use of language analysis software known as Leximancer
(version 4) [45] to quantify and display the conceptual
structure of the interviews: the presence of key concepts,
as well as the frequency of co-occurrence of key concepts (or main relationships between key concepts) in
the interview transcripts. The Leximancer program is
used in this study as a quantitative tool for a first stage
content analysis to avoid the analyst fixating on singular
concepts or terms and help reduce researcher bias. It
draws on approaches in computational linguistics and
has been described by its designers in their validity evaluation study [46] in following manner. The software is a
highly iterative numerical model that operates to render
large amounts of language data into a complex network
system. In simple terms, it automatically selects a ranked
list of key words in a set of documents on the basis of
their frequency and co-occurrence i.e. use together. The
program then builds a thesaurus which extends the seed
words into weighted terms called concepts. The text is
classified into text blocks (normally of a few sentences)
to produce a concept index and a concept co-occurrence
matrix. The software then calculates the relative cooccurrence frequencies of the concepts to obtain an
asymmetric co-occurrence matrix. The matrix is used
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to produce a concept map informed by a clustering
algorithm [46].
We believe that the whole field of computational linguistics offers much to the empirically minded health
sciences. Readers are referred to the designer’s validity
evaluation for more technical information on the Bayesian
decision-theory design of the software [46]. Thirty-six
studies in the database SCOPUS refer to Leximancer in
their abstract or title and key words, with 8 of these in the
health sciences, mostly studies of doctor and patient perspectives gathered from qualitative data [47-54].
The use of the software in this study involved selection
of key concept words by the researcher. The key concept
words were designed to be words that were meaningful
descriptors of both the processes of policy-making and
also of research. The key concept words were all those
research and policy words in a list of common words
used by policy-makers in the transcripts, as identified by
the software:
 research concept words were : research, academic,

methods, evaluation, analysis, literature, quantitative,
qualitative
 policy concept words were: policy, policy-makers,
implementation, consensus, options, improvement,
decision.
The Leximancer program was used to ‘heat-map’ these
key research and policy concepts as dark red to bluish
spheres on the output map the software provides (different
algorithms are available for clustering the concepts, however, a simple linear algorithm was selected for this study).
As the concept map is stochastic (it can appear slightly
differently depending on the fuzziness of words though
the fundamental relativities remain unchanged), the concept map procedure was repeated 10 times.
The study also involved a separate subsidiary analysis
of ‘sentiment words’ associated with ‘people types’ in the
interviews. This was designed to explore further whether
common terms used by policy-makers in referring to
different social groups were differently associated with
negative or positive sentiment words (in the extensive
Leximancer thesaurus). Thus, the analysis involved mapping, in a separate quadrant table, the presence and relative frequency of co-occurrence (with sentiment words)
of the following ‘people type’ words in the language of
policy-makers: policy-makers, university, academic, scientists, patient, practitioners, clinicians, legislator, politicians,
stakeholders, community, society, people.
A critical feature of Leximancer is that it allows the researcher to access all language data selected by the software to form the basis for the software output. This is
made possible through the interactive nature of the software which presents the researcher with multiple windows
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through which language data can be scrutinised. Accordingly, the researcher scrutinised all text blocks selected by
Leximancer for each of the key concepts used, in the
context of the original interview transcripts. The researcher also manually scrutinised all text blocks selected
by the software for the quadrant table, associated with
negative or positive terms. In short, the Leximancer procedures were conducted in an interactive, iterative fashion
that involved scrutiny of the original dataset through
Leximancer’s data windows, and cross-checking of the
validity of the concepts used.
Stage two

Qualitative analysis of extracts selected by Leximancer
as characteristic of key concepts. The qualitative analysis
was framed by critical discourse analysis to allow us to
move beyond simple description of content to examining
how the language of policy-makers worked in more subtle
ways in its explanations of the nature of useful research
and the evidence-policy divide. Critical discourse analysis
is a more traditional and well-established approach that is
often associated with founding thinkers on power and language such as Fairclough [55], Foucault [56-59], Bourdieu
[60-62], and accordingly a summary only is given here. It
is a growing area of application in health studies with 700
discourse analyses in PUBMED, 600 in the last decade,
across a wide range of health practice and policy areas
[63-73]. However, critical discourse analysis has not yet
been used to understand the ways health policy-makers
describe the evidence-practice divide.
Critical discourse analysis involves a focus on the subtle nature in which language works to shape meaning—
in this study the meanings created in discussion of
the evidence-policy divide. The traditional focus of such
analysis is first on establishing a global hierarchy or
‘order of discourse’ (dominant narrative forms) and, second, on analysing how language works in almost invisible ways to naturalise certain assumptions as truths that
serve the interests of certain social groups [57,58,74].
We hypothesised that the extracts of interviews identified by Leximancer under the different key concepts
would offer windows of opportunity for understanding
how policy-makers used language to legitimate or naturalise their understandings of the evidence-policy divide.
Accordingly, using critical discourse analysis in this way
allowed us to explore how policy-makers are themselves
meaning-makers of understandings about the evidencepolicy-and-practice divide.
Our procedure in employing this key aspect of critical
discourse analysis—how language works to normalise
assumptions about the evidence-policy divide [56,57,74]
—was as follows. For each of the key research and policy
concepts used in this study, the researcher scrutinised
each and every extract or ‘text block’ selected by the
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software as an instance of that concept (again, in the
context of the original interview transcript). The researcher described the way the language in that extract
worked to normalise a particular view of the evidencepractice divide. These descriptions are summarised in
this paper in conjunction with the software output (the
concept map and quadrant table). Our focus on the way
language works to ‘normalise’ or make certain assumptions appear natural, in line with the discourse analysis
literature [56,57,74], explains why we did not choose to
use other methods for stage 2, such as grounded theory,
which do not begin with this premise about how language works.
In summary, our method aimed to use the strengths of
critical discourse analysis (analysis of the subtle nuances
of language) with the strengths of software-based computational linguistics (offering greater reliability in the
initial gross language scoping exercise to establish the
larger hierarchy of key concepts). Our use of a ‘critical
computational linguistics approach’ was designed to help
overcome the acknowledged reliability concerns about
critical discourse analysis while also helping deliver the
richer and more nuanced discussion that content analysis can sometimes lack as an essentially descriptive
approach [46,75,76]. Accordingly, our epistemological position might be described as a ‘middle road’ between the
philosophical traditions that inform critical discourse analysis in which meaning is highly relative and subjective,
and the positivist demands of health sector research for
empirical veracity and quantification. In this epistemological framework, the production of meaning occurs in a
zone of collaborative human and artificial intelligence not
imagined by the founding figures of critical discourse analysis [56,77,78]. Yet our study is informed by a premise
consistent with their fundamental insights i.e. that the
evidence-policy divide is a social construct actively produced in the language of policy-makers.
While the first author EB conducted both the interviews and produced the first draft of the analysis, we do
not believe that exposure to the context of the interviews (implicit cues such as tone of voice) could somehow bias that first draft, which was checked and refined
in collaboration with the second author BS. The fundamental conclusions of the study are also founded in the
machine-driven Leximancer software output. Conclusions from the qualitative analyses are documented with
supporting quotations from interviews in the results section. In such an epistemological approach the goal is not
to free language data entirely from interpretative constraints, but rather to deliver an interpretation that is supported by evidence triangulated through the dual methods.
Further simple manual checks (readings of the paperbased versions of the interview transcripts), were performed for all interviews to ensure that the findings so
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obtained had not omitted anything important or introduced anything inconsistent.
Ethical approval for the study was obtained from
Tasmania’s Human Research Ethics (Tasmania) Network,
in line with requirements for the conduct of research by
Australia’s National Health and Medical Research Council.

Results
The concept map

Figure 1 provides a map of the key research and policy
concept words using the topical (linear) clustering algorithm in Leximancer. It also shows a grey network of
connections between concepts. The lines between the
concepts and CEO tags show typical pathways between
the concept terms in the language data. The warmth of
the circles indicates the overall relative frequency of
terms. The closeness of concepts indicates their contextual proximity when all other concepts are considered.
Not surprisingly, the broad concepts ‘research’, ‘policy’
and ‘policy-makers’ are most frequently found: they have
a 100%, 86% and 81% likelihood respectively of being
found in any one of 2,414 text blocks (of about one
paragraph each) from all the interviews included in the
study. In relation to paired concepts or co-occurrences,
the concept of ‘research’ is most associated with methodological terms like ‘qualitative’, ‘quantitative’, ‘methods’,
as well as ‘university’ which respectively have a 96%,
89%, 86% and 78% likelihood of being found in the same
text block as the term ‘research’. The concept of research is least associated with terms like ‘consultation’,
‘analysis’, ‘data’, ‘literature’ (14%, 17%, 23%, 24%). In contrast, the policy concept is most associated with terms
like ‘policy-makers’, ‘decision’ ‘conclusions’ and ‘development’ (99%, 88%, 80%, 64%). The policy concept is least
associated with ‘qualitative’, ‘quantitative’, ‘methods’, and
‘improvement’ (21%, 19%, 18%, 11%). Thus, one broad
finding is that the decision-making, conclusions-oriented
world of policy-making is constructed separately, but
not exclusively, from the methodologically-based world
of research.
This does not mean that policy-makers discussed research in terms that suggested it was irrelevant to their
needs. In fact, the policy-makers’ discourse about ‘research’ in the 569 text blocks where the term is used is
not a discourse of devaluing but rather of normalising
the idea of a distance between researchers and policymakers as a function of the technical nature of research
and its credibility and accessibility:
Researchers have to keep in mind the audience that
they have, and I am certainly not criticising the
members of Congress in any way, but recently
someone pointed out here the fact that there are
virtually no economists that are members of Congress
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Figure 1 Concept map of individual CEO interviews.

and with many of these issues the economics are
critical, and so it is trying to go up to members of
Congress with an elegant formula that has been
modelled to perfection, but if you can’t explain it in a
way that makes sense, or is going to be able to be
implemented in a way that they will be able to explain
to the people who they serve, ultimately it will sit on a
shelf. (CEO 4 USA)
These people are inundated with research. They’re
inundated with papers, they’re inundated with things
that they need to read to understand more fully what’s
going on. I think that most of the time if they feel that
the research is sound that they go with it. What
makes them have confidence in the research probably
depends on where the research comes from, the
credibility of the researcher themselves—in other
words maybe Harvard would be more credible than
the University of Bermuda or something. If the
research is done by somebody they know—which
doesn’t happen very often—that enhances the
credibility. Probably who financed the research I think

is incredibly important, particularly in medicine and
drug company studies etc. And quite honestly how
the research is presented, if it’s really good research
and it’s presented in a very easy to read and
understandable manner I think it’s much more
credible. (CEO 6 USA)
The discussion of ‘qualitative’ and ‘quantitative’ methods in 23 and 18 instances of uses of these terms tended
to position qualitative research as non-technical and
therefore more able to operate in the world of policymaking, albeit with its own limitations. Quantitative research was valued but positioned as a more specific
cause of the policy-practice divide in part due to a lack
of technical capital among policy-makers:
I think we do have a problem. There are two bits to
the problem; one is that in terms of health system
policy, health system management, health system
development, we’re sort of frightened about the
quantitative type of analysis that our scientific
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colleagues are used to. And they are often very
sceptical about the qualitative type of stuff that we
would tend to do. There’s a problem there. So when
we try and present policy which we say has a good
evidence base to it, it’s often not respected or
regarded by clinicians who in reality have to then go
and implement that policy. So that does exist, and
part of it is. . . us understanding and accepting that
there is a genuine need for good solid quantitative
research to take place in certain areas. (CEO AUS)
However, the evidence-policy divide was also positioned
as being about the limitations of research methodology itself. This was apparent even in the use of terms least associated with ‘research’. For example, in the 15 instances
where research was discussed in the context of ‘data’, the
language of policy-makers tended to describe a kind of
real world information for policy-making as shaped by
their own complexity-oriented intuitions about those contexts that formal research, including of community opinion, may not properly capture:
I like to see a properly conducted survey that gets to
the grass roots, that gets to the patient. That’s what
would convince me: that the question is properly
structured, it’s open ended, it’s not leading question
and it’s asking the right people. I’m very convinced by
that kind of survey which would be my number one
thing. My number two would be does it feel right, is
there a sort of internal logic to what’s being put
forward: if I put myself in the patient’s shoes can I
understand that they would feel that way. . .. the
intuitive logic of it, does it feel right that people
would be that way. If it doesn’t feel right then I’ll look
more closely at their methodology and think maybe
they asked leading questions and maybe they’re
drawing conclusions from data that theyshouldn’t.
(CEO HONG KONG)
The role of research in policy decision-making is described typically in the 57 instances where the term ‘decision’ was used as highly fallible and susceptible to the
political exigencies of that real world decision-making.
Policy-makers described evidence used in policy-making
as too often shaped from its inception by the need to support an outcome that has already been decided, though
that was not the kind of evidence-based policy-making
they preferred:
. . . there’s an awful lot of research questions that
manifest from ‘justify this for me’ or ‘construct it in a
way to support the decision that they want to make, is
going to be made’. I think that’s bad research. It does
look at a specific set of issues, but it doesn’t actually
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help you inform policy. It’s probably motivated by
some managerial, political or ad hoc approach to
research. If you want to sit down and say—and this
just won’t happen but, you know, ‘How should you
design a perfect health care delivery system?’ and
‘What policy do you need to implement around that,
around the social fabric of society, around the cultural
influences, around how much you’ve got to spend,
what the disease profiles are?’ You know that’s where
you would really love to be, doing that and actually
saying, ‘So what would be the most interesting, the
most beneficial policy to come out of that?’
(CEO 2 AUS)
The language of policy in these interviews does not so
much devalue the contribution of research to ‘change’ in
the 12 instances where this term occurs, as suggest that,
while clinical departments do follow international research, clinical practice ideally operates on an expanding
frontier of innovation that cannot always wait for sound
evidence:
Lord Darcy came to see us the other week because
the government’s published a research commissioning
standard and policy—but it’s too late in the year, it has
already happened because good innovative centres see
the horizons coming. They network clinically,
internationally. They observe research that’s beginning
to emerge, even when some of it is a little tenuous
and crude, and build upon that and then work
towards appropriate change. . . in a large clinical
centre the role really is to keep pushing the
boundaries, to continue innovating and not always
wait for the well-founded evidence-based practice.
(CEO 1 UK)
Yet it is also not the case that these policy-makers
positioned policy-making as being able to achieve improvement unproblematically in a non evidence-based
zone. The language used by policy-makers suggested the
issue is more that the dominant research methods in
health don’t engage with the needs of system improvement. In the one instance where policy was associated
with the term ‘improvement’, it was in a manner that positioned classical empirical health research as being poorly equipped to engage with the imperatives of system
improvement:
Health systems certainly are very difficult to define
through hypothesis-driven research. The systems
seem to change too quickly. I wonder sometimes
whether the classic scientific methods of defining
hypothesis, holding conditions stable and changing
one variable, whether the training of many science
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folks engaged with health policies—that background,
that training—is sometimes not useful in terms of
understanding the descriptive methodologies and the
quality improvement methodologies that tend to
inform policy. You know people with a scientific
background tend to look for that hypothesis during
research and when it’s not there they say the
material’s not useful. That’s a real problem.
(CEO CANADA)
Sentiment in policy-maker interviews

Figure 2 provides the detail of all the terms used for
people in the language of policy-makers associated with
positive and negative sentiment words in this interview
set. The relative frequencies or conditional probability of
each term such as ‘scientists’ or ‘patient’ or ‘academic’ or
‘policy-maker’ being found with positive or negative sentiment words is mapped by grouping interviews by country (country groupings are for the sake of convenience
only so that the quadrant will more clearly display differences between people type words in the language of
policy-makers).
That is, Figure 2 represents the extent to which concepts about different kinds of people are found in the
positive or negative language of CEOs grouped by country. The explanation that follows has been closely adapted
from the software output [79]:
This is a high-level, visual chart displayed in a 'magic
quadrant’ format. The axes are:
 Relative Frequency: a measure of the conditional

probability of the concept, given the category (either
positive or negative sentiment); for example, given
we are looking at occurrences of either a positive or
negative sentiment, how likely is it that the concept
‘academic’ is mentioned
 Strength: a measure of the conditional probability of
the category (in this case either positive or negative
sentiment) given the particular concept; for
example, given we are looking at occurrences of the
concept 'academic’, how often is it mentioned in
either a positive or negative sentiment, i.e. the
‘strength’ of the association.
There are four pertinent areas to the quadrant: concepts in quadrant 1 (bottom left) are weak in terms of
their frequency of use with sentiment associations and
more likely to occur with negative terms while concepts
in quadrant 4 (top right) are strong and more likely to
co-occur with positive terms. The differing colours of
the concepts denote their association with the particular
country where the CEOs are located [79].
In other words, the y axis relates to frequency of association with sentiment words, while the x axis ‘splits’
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those associations by whether the majority of instances
of the concept are positive or negative. Concepts located
above the x axis are majority positive associations, while
concepts located below the x axis are majority negative
associations. The word ‘majority’ is important here because in practice each concept must be placed in a way
that accounts for what is generally true for that concept
i.e. true when all instances of text blocks for that concept are considered. Rarely will a concept be exclusively
positive or negative because for that to be true the concept must be uniformly referred to (negatively or positively) across all instances of that concept. There are
exceptions: the ‘legislator’ concept was mentioned only
about 1 out of a hundred times by USA CEOs but was
positive 100% of the time (this is not a finding that suggests USA CEOs think highly of legislators, simply that
their infrequent mentions of legislators in the language
of sentiment were positive, which makes some sense in
the context of the politically sensitive environments to
which they are habituated).
Thus the quadrant describes four dimensions: more frequent (and either majority positive or majority negative)
versus less frequent (and either majority positive or majority negative). For example, looking at the legend for
Figure 2, the fact that the Singapore CEO’s use of the
‘policy-maker’ concept lies far along the × frequency axis
(which extends to 45 out of a 100 times in the language of
sentiment) suggests a relatively high frequency of sentiment association. That is, in a relatively greater number of
times compared to other CEOs (36% to be precise when
checking the data output) in the sentiment language this
CEO used, was the ‘policy-maker’ concept used. This begs
the question of what kind of sentiment language was used
with the ‘policy-maker’ concept by this particular CEO.
The y axis (which extends to 100 out of a 100 times in the
language of sentiment) provides the answer: mostly negative. The data output confirms that in 7% or seven out of
a hundred times in which the concept ‘policy-maker’ is
used by the Singapore CEO in sentiment language is it
associated with positive sentiment (all other sentiment
associations are negative, which means the majority of
associations for this concept are negative, and the concept
therefore lies a long way down from the x axis).
Accordingly, the quadrant allows us to consider whether
these interviews support the broad hypothesis that policymakers use terms associated with academics more negatively than terms associated with other groups i.e. when
asked to describe the features of research they find useful.
It is worth noting that it does not measure the production
of concepts in emotionally neutral language.
Care needs to be taken in interpreting Figure 2. For
example, the fact that one policy-maker (a Norwegian
CEO—see figure legend) used the concept word ‘politician’ more often in more positive language than other
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Legend
Norway
USA
Australia
New Zealand
Canada

UK
Denmark
Singapore
Hong Kong

Figure 2 Quadrant map of references to ‘people types’ associated with sentiment terms in CEO interviews, by country.
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policy-makers, is not a finding that can be used to ‘determine’ that interviewee’s ‘true feelings’. There are many
reasons that such an interviewee might produce more
positive associations in an interview context, for example, a well-cultivated habit of self-preservation. However,
viewed in aggregate, such a sentiment analysis can offer
indicative evidence to help explore hypotheses such as
‘Policy-makers uniformly hold more negative views of
researchers than they do of themselves when talking
about policy-relevant research.’ Accordingly, the discussion that follows should be considered as an extension of
our main analysis—as indicative supplementary evidence.
Figure 2 suggests that, when using this ‘language of
the emotions’, policy-makers referred to themselves far
more often than they did other groups. This is not really
surprising given that they were being asked to focus on
their own needs. However, there is no evidence of systematic differences in the degree to which references to
policy-makers versus other groups such as academics or
university communities were associated with positive or
negative sentiments (i.e. when describing policy-relevant
research methods as the study asked them to do). In
fact, Figure 2 suggests some policy-makers did tend to
refer to academics and university communities more
positively than they did themselves, where such references occur. The language in these interviews works
to normalise the view that policy-makers own the
challenge of developing better research methodologies
for policy i.e. that it is their challenge as much if not
more than research communities. Yet there are no references to academics and university communities that are
definitely positive, as for example, in the following example of the most positive reference to academics found in
the interviews:
So you have to sort of step down from the high
academic horse and get into this everyday prioritising,
discussions, you have to play a role in the newspapers,
you have to play a role—you have to address, directly
address policy-makers both on the political and
administrative level, so your research is sort of playing
to the context where decisions are made. If your
research is not placed within that context the chances
are that they won’t play any role when the decision is
made; but if you’re able to place your research result
into that context arena of decision-making then it
might be influential on the eventual outcome of
policy-making. (CEO DENMARK)
Manual checks of sentiment-linked references to academics and university communities in these interviews
versus those that were not sentiment linked were also
undertaken using Leximancer. These suggested that a
general lack of engagement with academic and university
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communities (not necessarily evidence per se) might explain the limited references to them in the ‘language of
emotion’ of these policy-makers i.e. language that is apparently sentiment-linked. It appears from Figure 2 that,
when discussing features of useful research, generally
policy-makers in this study did not see a more positive
role for themselves than they did for academics.
While Figure 2 suggests that the language of discussion about research practice is not a language that is
generally positive, scrutiny of how these policy-makers
used the word ‘community’, suggested they naturalised
the idea of their own evidence-based commitment to
their communities of interest. That is, they positioned
themselves as having a key role in understanding and
using information about local communities through the
mechanism of authentic evidence. Negative sentiment
was more about the ability of existing research practices
to engage with the complexities of measuring community views and experiences than the communities
themselves. Such language suggested that policy-makers’
struggled to find subtle and (technically and politically)
robust methodologies of community-based research. In
particular, policy-makers portrayed community-based research involving stakeholders as critical to authentic,
democratic, evidence-based policy-making—almost normalising it as a contested site of evidence on which policies were won and lost. This was especially notable in
the USA interviews:
It really is an area with a lot of pitfalls and it’s an area
I think where a researcher’s credibility really is put on
the line, particularly when you’re asked to draw
stakeholders together and get their points of view. It’s
very easy to think of the people the researcher knows
or has the ability to get in contact with as
representative. I’ve seen a lot of effort lose credibility
and the goodness that’s in the work, the truths that
are there, not get put to use because it’s very easy for
policy-makers who may disagree with the findings to
discredit stakeholder-based work. I guess drawing the
tent as broadly as possible would be, you know, an
obvious bit of advice and probably touching base early
on in the design with who the likely opponents or nay
sayers will be and having them suggest people who
need to be included. (CEO 4 USA)
The role of expert opinion was little present in the
‘language of emotion’ of policy-makers in these interviews. However, there was at least one CEO who positively
positioned research capacity-building among practitioners who were described as beginning with a clinical
‘research bias’ based on practical experience but ultimately offering the potential for research translation into
healthcare benefits:
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It’s not just the training, it’s actually bringing on board
on the clinical side practitioners with a research bias
and encouraging them during their career
development to be working alongside the scientists in
all that they do—and endeavouring to influence and
steer so that we can begin to see practical benefit.
(CEO UK)

Discussion
Care must be taken not to infer that the structure and
nature of this language dataset as found by our twostage method is representative of the nature of the larger
evidence-policy divide. At the same time, these interviews do not support simplistic definitions of policymakers and researchers as coming from two irreconcilable worlds. It appears in these interviews at least that
the worlds of policy and research are seen as separate
but certainly not exclusive. Understanding their rich
interface better is an important challenge for all those
who want their research to better shape the health systems that practitioners and patients experience. Policymakers in this study did not so much devalue research
as distance research in ways that suggest they have
their own language for legitimating its non-use—just
as researchers do.
The view that the evidence-practice divide is also
partly about the methodological limitations of research
was also supported by these interviews. In this study, the
needs for research into community health and system
improvement were portrayed as complex and not well
served by existing research evidence available to policymakers. In short, the way policy-makers described the
evidence-policy divide suggested not simply that they
need technical quantitative research simply presented. It
also suggested that they need technically and politically
robust complexity-oriented evidence for local community health and service development.
‘Complexity-oriented research’ in these interviews can
be defined as research that authentically and accurately
captures the rich contexts in which policy-makers operate. This may be described as ‘community-based research’
where it involves an engagement with the local stakeholders important to policy-making—their views and
experiences as part of ‘consensus-making’ or ‘consensusfinding’ for policy. This study does not offer evidence
about the quality of such research, although our introduction does observe that the effort to capture contextual
complexity is key in contemporary debates about the usefulness of research
Interestingly for those who have perpetuated the ‘two
worlds’ view of the evidence-policy divide, policy-makers
did not describe a more positive role for themselves than
they did for academics in meeting such methodological
challenges and addressing such evidence deficits. That
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they positioned community-based research as a vital evidence mechanism for policy is instructive. That such
community-based research lies outside dominant definitions of high quality research for health exemplified by
the CONSORT statement [80] may itself have worked to
prevent development of excellence in local community
and services-based research.
Such observations follow from the evidence of these
interviews if we accept that there is some truth in how
the CEOs understand the evidence-policy divide. However, we are conscious also that studies such as this one,
asking the most senior health agency staff to describe
the features of policy-relevant research, offer their findings in contexts where other triangulating evidence is
very limited. For example, is it possible that all these
interviewees have misunderstood the nature and purpose of quantitative and qualitative research? The involvement of CEOs from different countries, many with
advanced research qualifications such as Ph.Ds, and their
daily involvement with research evidence, makes it unlikely that they do not understand the fundamentals of
research practice. At the same time, in a century in which
many examples of quite ‘technical’ qualitative research
also exist, the fact that policy-makers described qualitative
research as having a popularist or non-technical nature
offers support for the view that their ideas about research
are just that. It is clear that they are only one kind of
observer of the evidence-policy divide, albeit critical observers. More junior health agency staff more intimately
involved in evidence-based project work may have offered
different perspectives.
Notwithstanding, to shape the evidence-using behaviour of policy-makers, arguably we first need to understand how they perceive evidence—where this study
has aimed to make its contribution. The fact that these
CEOs have these kinds of views of research offers indicative evidence about the myths about research that
researchers need to engage with if they are to persuade
senior policy-makers of the value of their evidence.
Even if these particular senior policy-makers are entirely
wrong in their understandings of the true causes of the
evidence-policy divide, this study suggests how their
understandings may be working to perpetuate that divide. In practical terms in the health sciences, this may
mean that researchers need to pay more attention to
conveying the value of generalisable clinical quantitative methods—not only building excellence in applied
community-based methods. For example, this study suggests that the work of colleagues such as Tunis developing pragmatic clinical trials [81] needs to be better
conveyed to policy-makers who view RCTs very traditionally. The value of new developments such as ‘Comparative Effectiveness Research’ focussing on the policyrelevant question of ‘What works?’ [14] may also need to
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be better conveyed to policy-makers to help reinvigorate
their ideas of research relevance.
Our final discussion points relate to our own methodological limitations and strengths. In relation to our
sample, it is not clear how representative these policymakers are of all health agency CEOs. The small numbers involved meant that the study focussed on aggregating viewpoints rather than examining regional variations
in CEO perspectives. That is, we did not feel we could
make conclusions about differences between countries
or states in a context where we knew our sample was
not representative of all state/provincial and national
agency CEOs. Even if a representative sample was obtained we are uncertain that it would be accurate to treat
CEOs as ‘data carriers’ of regional variations because
many of them have international careers and their reference points often appeared to come from their experience in countries other than those whose health systems
they administered at the time of the interviews. Accordingly we emphasise the value of the study as an aggregation of viewpoints—insights about a global social group
we describe as ‘health agency CEOs’. We point to how
the perspectives of health policy-makers at this level are
rarely included in definitions of the research-policy-andpractice divide. The substantial resources we invested in
locating and approaching them, and the general difficulty of accessing professionals at this level in health
systems is perhaps part of the reason for their lack of
visibility in the literature.
In relation to our analytic procedure, this aimed to
combine the strengths of two ways of analysing language in order to help overcome the weaknesses of both.
Leximancer offers an approach to content analysis of
qualitative data but as a machine-driven, content-focussed
method does not offer a theoretical approach to understanding language that can also help analyse its subtle nuances. Critical discourse analysis offers a well-established
theoretical framework for analysing how meaning works
in language but has been criticised for a perceived lack of
empirical rigour and reliability [76]. Rather than arguing
for any method, we believe that an openness to the possibilities of combining different methods may help qualitative research better satisfy the needs of the health sciences.

Conclusions
We conclude that these particular interviews do not
support simplistic definitions of policy-makers and researchers as coming from two irreconcilable worlds. The
policy-makers interviewed for this study value qualitative
and quantitative research. However, they suggest that to
be policy-relevant health research may need to focus
on building complexity-oriented research methods for
local community health and service development. Researchers also need to better explain and develop the policy-

Page 13 of 15

relevance of large statistical generalisable research designs.
Policy-makers and public health researchers wanting to
serve local community needs may need to be more proactive about questioning whether the dominant definitions
of research quality and the research funding levers that
drive university research production are appropriately inclusive of excellence in such policy-relevant research.
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